| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |